Physician profile
Justin Mark Cappuzzo
NPI 1538517164
$38,265.94
in general payments reported to CMS, 2019-2025
25 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $285 · 2021: $312 · 2022: $5,481 · 2023: $7,397 · 2024: $12K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $7,278 · Travel and Lodging: $4,152 · Food and Beverage: $4,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,000.00 |
| Consulting Fee | $7,278.43 |
| Travel and Lodging | $4,152.05 |
| Food and Beverage | $4,136.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,126.40 | 2022-2025 | Pipeline, Axium Primetm, Solitaire X |
| Penumbra, INC. | $8,027.22 | 2021-2025 | Penumbra System, Benchmark, Smart Coil |
| Qapel Medical INC | $6,361.53 | 2023-2024 | |
| Stryker Corporation | $1,545.36 | 2022-2025 | Target, Trevo, Adherus Autospray Dural Sealant |
| Canon Medical Systems USA, INC. | $1,250.00 | 2022 | |
| Medical Device Business Services, INC. | $774.95 | 2019-2021 | |
| Imperative Care, INC | $434.36 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| W. L. Gore & Associates, INC. | $350.00 | 2022 | |
| Orthofix Medical, INC. | $331.81 | 2019-2023 | Physio-Stim |
| Integra Lifesciences Corporation | $159.15 | 2019-2021 | |
| Depuy Synthes Sales INC. | $152.13 | 2022-2023 | Embotrap, Cerepak Uniform |
| Microvention, INC. | $133.99 | 2024-2025 | Scepter C, Web Aneurysm Embolization System |
| Si-Bone, INC. | $126.16 | 2022-2023 | |
| Globus Medical, INC. | $109.21 | 2019-2023 | Coalition Mis / Mis Ti |
| Abbott Laboratories | $86.50 | 2021-2025 | Xact |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $79.78 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $48.65 | 2024 | Floseal |
| Providence Medical Technology, INC. | $35.70 | 2024 | |
| Zimmer Biomet Holdings, INC. | $27.34 | 2019 | |
| Sanara Medtech INC. | $21.26 | 2024 | Celleraterx |
| Kerecis Limited | $20.99 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Aesculap, INC. | $17.86 | 2023 | M.Blue |
| Gt Medical Technologies, INC | $17.71 | 2025 | Gammatile |
| Scientia Vascular | $14.58 | 2022 | |
| Kls-Martin L.P. | $13.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Cappuzzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.